A prospective, single-arm, open-label, non-randomized, phase IIa trial of a nonavalent prophylactic HPV vaccine to assess immunogenicity of a prime and deferred-booster dosing schedule among 9-11 year-old girls and boys - clinical protocol
Zeng, Yi, Moscicki, Anna-Barbara, Sahasrabuddhe, Vikrant V, Garcia, Francisco, Woo, Heide, Hsu, Chiu-Hsieh, Szabo, Eva, Dimond, Eileen, Vanzzini, Susan, Mondragon, Angelica, Butler, Valerie, DeRose, Hillary, Chow, H-H Sherry
Published in BMC cancer (01.04.2019)
Published in BMC cancer (01.04.2019)
Get full text
Journal Article